The dangers of endocrine disrupting chemicals (EDCs) for human health and the environment have long been documented and the evidence keeps piling up every day, yet Europe's approach to this challenge has been lukewarm, writes Genon Jensen.
Cosmetic products are not only skin deep. They bring real benefits to people’s lives and contribute massively to Europe's economy. It is time to recognise their broader contribution, argues John Chave.
Plans to tackle the problem of illicit tobacco by using track and trace technologies are gathering momentum among European policymakers. But Juan Yañez warns that concerns about the type and timing of the technology need to be raised.
Antimicrobial resistance (AMR) is one of the greatest global health threats. Resistant bacteria make infectious diseases like tuberculosis and pneumonia difficult or impossible to treat, writes Norwegian Agriculture Minister Jon Georg Dale.
In the Western Balkans, air pollution can be a fatal problem, made worse by some of those countries’ energy policies. Ioana Ciuta sheds light on the region’s developing crisis, which is claiming lives at an alarming rate.
Whether or not Donald Trump is taking part in efforts to protect the planet, inventions and technological progress are filling an important gap and the EU is playing a role bigger than generally assumed, writes Eli Hadzhieva.
Consumers make hundreds of choices every day, some of which imply weighing the tradeoffs of joy versus long term health. These are highly subjective decisions, and in a free society adult consumers should have the right to make these choices and not have them dictated to them by public health tsars, writes Fred Roeder.
On Tuesday 6 June, a delegation for the Paris bid for the 2024 Olympic and Paralympic Games will be received by the European Parliament in its assembly. It is a big opportunity for Paris, and also for the European Union, writes Julian Jappert.
The EU wants to tackle counterfeit pharmaceuticals and tobacco. Tracking, tracing and authentication (TT&A) has a big role to play in this. But who should be tasked with implementing and monitoring it? Craig Stobie explains how the problem should be handled.
Europe is still the most powerful international player in global health. But in an increasingly multipolar world, where differences between the developing and developed health worlds are dissolving, the way we look at global health is outdated, writes Johanna Ralston.
Putting more than 10 years of paralysis behind it, the European Commission finally launched a revision of the directive on the prevention of occupational cancers in May 2016. Lawmakers can now address reprotoxic substances in the workplace, writes Laurent Vogel.
As safety watchdogs battle over just how toxic and dangerous Monsanto’s controversial weed-killer glyphosate actually is, the even more toxic half-brother from Bayer, glufosinate, is making a timely return, warns Mute Schimpf.
Unless the European Commission changes its attitude, the innovation gap between Europe and the US will likely increase, and it could be overtaken soon by China, with dire consequences for living standards, warns Philip Stevens.